CHPA Praises Senate Introduction of OTC Monograph Reform Bill

Share page:

Press Releases and Statements | Oct 30, 2019

The Consumer Healthcare Products Association (CHPA) issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R-Ga.) and Bob Casey (D-Pa.):

“CHPA thanks Senators Isakson and Casey for reintroducing this important bipartisan legislation which would modernize the regulatory system overseeing the majority of over-the-counter (OTC) medicines. If enacted, the bill would make important improvements to the OTC Monograph system, helping to increase efficiency and transparency, while providing the Food and Drug Administration (FDA) with the authority and resources it needs to continue protecting and advancing the public health.

“This bipartisan legislation enjoys the support of a diverse coalition of stakeholders representing the regulatory, public health, and industry sectors. We look forward to the Senate HELP Committee markup tomorrow and hope to see the bill advance in the near future.” 

Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system more than $7, contributing a total of $146 billion in savings each year. CHPA is committed to empowering consumer self-care by preserving and expanding choice and availability of consumer healthcare products.